Universal Medica Group and its renowned partners are pleased to organize the 2nd edition of the Innovation Days event to be held on 26, 27 September at the Cité Universitaire Internationale of Paris – France.
The only international event in France entirely dedicated to Innovation.
Over 600 participants expected to attend the 2nd edition!
New for 2011: a space dedicated to the “Partnering Deal” in order to promote networking and develop partnership opportunities.
For more information, please contact: firstname.lastname@example.org
- MoH issues guidelines for price management in health care system
- China’s grassroots medical reform lagging – NDRC official
- CAS to set up brain mapping center with UPenn
- Beijing Municipality to subsidize treatment for disabled children
- Eli Lilly to set up health foundation with Beijing NPO
- UPMC enters China with KingMed Diagnostics
MoH issues guidelines for price management in health care system
(China MOH, 2011-05-27)
China’s Ministry of Health (MoH) and the State Administration of Traditional Chinese Medicine (SATCM) have issued interim guidelines for price management within the health care system. The guidelines set quotas on the number of price management specialists employed by hospitals. Institutions with more than 1,500 beds are required to have three to five full-time price managers, while those with less than 1,500 beds are required to have two to three, and those with less than 500 beds only one or two. Price managers’ responsibilities include cost calculation and pricing new services, as well as ensuring compliance with pricing regulations and handling price complaints. All hospital departments are also required to appoint a part-time price manager from among their staff.
MicroConstants China wins GLP from OECD
MicroConstants China Inc. has been awarded Good Laboratory Practice (GLP) by the Organization for Economic Cooperation and Development (OECD) for its analytical chemistry and pharmacokinetics (PK) lab, the company announced. The Beijing-based firm is the China subsidiary of San Diego, California-based contract research organization (CRO) MicroConstants Inc. It was established in 2007 and specializes in preclinical pharmacokinetics (PK) studies and clinical trial management. Inspectors from the Netherlands conducted a one-week inspection of the facility earlier this year, according to the announcement.
China’s grassroots medical reform lagging – NDRC official
(China NDRC, 2011-05-27)
Grassroots health reform in China is failing to keep up with the roll-out of the essential drug system, Sun Zhigang, deputy director of National Development and Reform Commission (NDRC), told officials in Bejing. In a video conference held by the State Council’s health care reform committee, Sun urged local governments to formulate timetables for implementing the “comprehensive reform” of grassroots health care. Comprehensive reform refers to the introduction of new management models for grassroots medical institutions, including a more competitive recruitment system and performance-based pay for staff, as well as a standardized drug procurement system and multi-channel subsidies, Sun said. More than 40,000 grassroots medical institutions have implemented the essential drug system to date, approximately 82.6 percent of the total, according to Ministry of Health (MoH) figures. But fundamental changes in management are necessary to ensure these institutions receive proper funding following the introduction of the zero markup policy for drug prices, which prevents medical institutions from relying too heavily on drug sales as a revenue stream.
CAS to set up brain mapping center with UPenn
The University of Pennsylvania (UPenn) has agreed to set up a brain mapping research center with the Chinese Academy of Sciences (CAS), the American university announced. According to the announcement, the facility will be named the CAS-Penn Center of Excellence in Brain Mapping, and will involve the CAS Institute of Biophysics. The location was not disclosed. The center will carry out research on the use of neuroimaging in basic and cognitive neuroscience, and will work on the development of novel imaging technologies. It will also provide specialist training and conduct studies in the detection, diagnosis and treatment of brain diseases.
China issues TCM guidelines for general hospitals
(China MOH, 2011-05-26)
China’s Ministry of Health (MoH) and the State Administration of Traditional Chinese Medicine (SATCM) issued interim guidelines for traditional Chinese medicine (TCM) services in general hospitals. According to the guidelines, the staff of general hospitals should include a senior director of TCM services, while a hospital’s TCM department and TCM pharmacy should each have representatives on its management committees. TCM services in general hospitals should cover at least processed TCM materials, finished TCMs, acupuncture and moxibustion. And a TCM department should account for at least five percent of a hospital’s total beds. Meanwhile, Grade III hospitals should offer TCM outpatient services in at least three departments, and Grade II hospitals in at least two. Hospitals can choose from among the departments of internal medicine, gynecology, pediatrics, bone trauma, dermatology and acupuncture and moxibustion. Furthermore, TCM dispensaries in Grade III institutions should stock about 400 types of processed TCM material as well as appropriate finished TCMs.
Synthes sets up geriatric fracture center in Guangzhou City
Synthes, a multinational manufacturer of orthopedic devices, has set up a clinic for geriatric fractures in Guangzhou Nanfang Hospital, a Synthes employee said. The center will conduct research of geriatric fractures and provide training for surgeons and geriatricians. It is Synthes’ first clinic in China. The multinational firm also hopes to set up centers in Shanghai and Beijing, according to a sales manager surnamed Chen with Synthes (Shanghai) Medical Trading Co. Ltd, the firm’s China subsidiary. U.S. health products giant Johnson & Johnson announced in April it has agreed to acquire Synthes, which is based in Switzerland and the U.S., for $21.30 billion.
Shenzhen City to test hospital alliance scheme
Shenzhen City plans to form 13 hospital alliances that will cover all the city’s districts, the Shenzhen Health, Population and Family Planning Commission (HPFPC) announced. According to provisional guidelines issued by the commission, each alliance will be composed of at least one Grade III general hospital, one Grade II hospital, and a number of Grade I hospitals and community health centers (CHC). The top-level institutions will handle difficult-to-treat patients transferred from lower-level affiliates, and will also provide training for medical staff from other alliance members. Furthermore, doctors from higher-level institutions will be encouraged to practice at lower-level member institutions, and lower-level medical institutions will accept the results of medical tests conducted by higher-level affiliates – hospitals in China often refuse to use test results from other hospitals, and require patients to be diagnosed in their institution.
Shaanxi People’s Hospital nurses respond to incentives
Shaanxi People’s Hospital is witnessing tangible results from its drive to improve the quality of nursing services, according to a statement on the provincial health department’s website. In March last year, the hospital became one of the first in China to adopt measures to improve nursing services after health authorities urged medical institutions to make improvements in the area. The hospital instituted performance-based bonuses are totaling RMB 5 million ($770,416) during the year, while the bonuses to night nurses were increased seven- to eight-fold. According to the statement, the measures have resulted in a 22.2 percent decrease in adverse nursing events and a 96 percent decline in patient complaints since they were adopted. There were a total of 2.18 million registered nurses in China as of the end of 2009, or 1.39 per 1,000 residents. The Ministry of Health (MoH) aims to more than double this figure by the end of 2020 to 3.14 nurses per 1,000 residents.
Beijing Municipality to subsidize treatment for disabled children
Beijing Municipality will subsidize treatment costs for all disabled children under the age of 16 starting June 1, China’s central government announced. The municipality has been testing the measure on a limited basis since 2009. According to implementation guidelines issued by the municipal government, the subsidies will be available for registered Beijing residents to treat certain disabilities at designated rehabilitation centers. The visually impaired will be eligible for a monthly subsidy of up to RMB 500 ($77), children with hearing, speaking, intellectual or limb disabilities will receive up to RMB 1,500 ($231), while those with mental or multiple disabilities will get as much as RMB 2,000 ($308).
China’s county hospitals suffer under $6 bln debt burden – expert
About 90 percent of China’s county-level hospitals are presently in debt and, as of the end of 2008, faced total liabilities of RMB 40.6 billion ($6.26 billion), state media reported . Many of China’s 9,621 county-level hospitals borrowed funds to make upgrades in recent years in order to boost patient numbers and revenue, with each institution averaging some RMB 26 million ($3.95 million) in debt. Average outpatient costs in county-level hospitals grew 5.8 percent on an annual basis in 2010, while inpatient costs up 5.9 percent, according to official figures. The central government last year announced plans to spend RMB 36 billion ($5.55 billion) over the next three years to upgrade 2,176 county-level hospitals, a move some analysts see as a means of mitigating the debt problem.
China: chronic non-infectious diseases, a major health threat
Chronic non-infectious diseases have become a major healthcare threat in China. Indeed, they account for 85% of total annual deaths in the country, according to a report released by the MoH. According to this document made public during a national forum in Chongqing on the control and prevention of chronic diseases, four types of chronic non-infectious diseases (cerebrovascular diseases, cancers, respiratory diseases and cardiovascular diseases) are the main causes of death in China. These disorders are also the leading cause of death worldwide or 60% of total worldwide according to WHO.
China cracks down on unlicensed drug e-commerce
China has launched a crackdown on unlicensed drug e-commerce, the State Food and Drug Administration (SFDA) announced. According to the circular issued by the regulator, the campaign will target the illegal sale of prescription drugs and false advertising for medicines to treat diabetes, hypertension, kidney disease, rheumatism, sexual dysfunction and dermatological. Websites that claim affiliations to the government or military will be particularly targeted. The SFDA has approved online drug sales for 35 drugstores , but the sale of drugs through unlicensed business-to-consumer (B2C) websites has been a problem. The drug watchdog will coordinate the action alongside the Ministry of Industry and Information Technology (MIIT), the State Administration for Industry and Commerce and the Ministry of Public Security.
UPMC enters China with KingMed Diagnostics
Marking its first medical services agreement in Asia, US-based medtech company, UPMC has announced that it will provide remote, second-opinion pathology consultations to KingMed Diagnostics, the largest independent medical diagnostic laboratory in China. Using equipment that scans glass pathology slides and stores and transmits the images electronically, KingMed will have the ability to seek second opinions on patient diagnoses from UPMC’s pathologists through a secure, Web-based telepathology portal. The service is expected to start by late summer. UPMC’s collaboration with KingMed is expected to include training for pathologists from China in UPMC’s Pittsburgh facilities and joint academic meetings as part of ongoing medical education in China.
Jiangbo Pharmaceuticals faces revenue decline
Jiangbo Pharmaceuticals, a pharmaceutical company with its principal operations in China, has announced that the company’s revenue in third quarter fiscal year 2011 has decreased by 29.2 percent to $ 18.1 million from $ 25.6 million in the corresponding quarter ended March 31, 2010. Gross profit of the company declined from 35.3 percent to $ 12 million from $ 18.6 million in the corresponding quarter ended March 31, 2010. On January 4, 2011, the company’s Hongrui factory was awarded with the Good Manufacturing Practices Certificate for Pharmaceutical Products by China’s SFDA. The GMP Certificate is valid until the end of 2015.
Eli Lilly to set up health foundation with Beijing NPO
Eli Lilly and the Beijing-based China Medical Foundation (CMF) plan to set up a health foundation, the U.S. pharmaceutical giant announced. The CMF-Eli Lilly China Foundation will provide grants for education, disease screening and doctor training in the areas of diabetes, tumors and men’s health, as well as central nervous system (CNS), musculoskeletal and cardiovascular diseases. Eli Lilly will provide RMB 1 million ($154,330) in start-up funds. CMF, a government-backed non-profit organization that provides funding to health projects, will screen grant applicants.